Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for HIV-Associated Osteopenia
NCT00102908Phase 2Unknown
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronate in osteopenia, osteoporosis, sponsored by National Institute of Allergy and Infectious Diseases. Status: unknown.
02
Drugs
zoledronate
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00102908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102908.